SolaxaTedcoBHIBioHealth Innovation, Inc. (BHI) proudly recognizes the $500,000 investment from TEDCO in Solaxa Inc., a Bethesda-based biopharmaceutical company. Led by Founder & CEO Christian Walker, Solaxa is a clinical-stage biopharmaceutical company developing a portfolio of aminopyridine drugs that both detect and treat ion channel dysfunction. Previous research has shown that aminopyridines can improve nerve signaling and muscle function in patients with Multiple Sclerosis, and Solaxa is presently researching additional benefits in patients with other nerve disorders. Solaxa is organized as a for-profit public benefit corporation, with a mission to advance scientific knowledge and deliver impactful and accessible therapies that improve outcomes for patients worldwide.   

Prior to this investment from TEDCO, Solaxa was recognized as the “Best of Montgomery” finalist at the 7th Annual BioHealth Capital Region Crab Trap Pitch Competition in September 2023. Even more recently, Solaxa was recognized as “Venture of the Year” by the Maryland Tech Council in May 2024.  

 

Solaxa was among the earliest recipients of Executive-in-Residence (EIR) advisory services provided by BioHealth Innovation (BHI) with funding from Montgomery County, Maryland. This program enables BHI and its EIRs to nurture the local life sciences ecosystem. It places seasoned industry professionals in advisory roles to support start-up and growth-stage companies in diagnostics, medical devices, digital health, bioinformatics, AI/machine learning, and therapeutics.

Thanks to BHI’s EIR program, Solaxa has benefited from the support of two of BHI’s EIRs: Jennifer Butler, who now serves as Solaxa’s Chief Commercial Officer, and Luis T. Gutierrez, Jr., who now serves as the company’s Chief Operating Officer. They have played pivotal roles in Solaxa’s journey, demonstrating the program’s impact in cultivating the local life sciences ecosystem.

“This investment from TEDCO is a significant milestone for Solaxa, validating the hard work and innovative approaches we’ve championed. We are excited to continue our journey, and we continue to benefit greatly from the support and expertise of BHI and its dedicated team,” said Luis T. Gutierrez, Jr., Chief Operating Officer of Solaxa.